Diseases, Conditions, Syndromes

FDA approves ozanimod for multiple sclerosis

The U.S. Food and Drug Administration has approved ozanimod, an immune-modulating therapy invented at Scripps Research, for the treatment of adults with relapsing forms of multiple sclerosis. The drug is also in advanced ...

Overweight & Obesity

Scientific community pledges to end obesity stigma

Coinciding with World Obesity Day, over 100 medical and scientific organisations have today pledged their support for a consensus statement that recognises unscientific public narratives of obesity as a major cause of weight ...

Other

Society is rejecting facts; medical researchers can help

One study says coffee is good for you, while another study says that it's not. They're both right, within context. This dichotomy together with an environment of distrust spurred by anecdotes, fake news, and to a large extent, ...

Medical research

Personalizing drug development using big data

A new computer program developed at the University of Arizona College of Medicine—Tucson and recently licensed to startup INTelico Therapeutics, LLC, is pushing the envelope of precision medicine. By integrating the genetic ...

Neuroscience

fMRI study reveals brain working's during navigation

(Medical Xpress)—A team of researchers affiliated with several academic institutions in the U.S. has learned more about the way the brain works as a person both visualizes taking a trip, and then as the trip is taken. In ...

Other

Sustaining biomedical research: Med school deans speak out

Cuts in federal support and unreliable funding streams are creating a hostile work environment for scientists, jeopardizing the future of research efforts and ultimately clinical medicine, according to leaders of the nation's ...

page 1 from 2